Oral e-Poster Presentations - Booth 4: Neuro-Oncology 3 (GBM & malignant gliomas)
Tracks
Mezzanine Floor
| Monday, October 14, 2024 |
| 9:30 AM - 10:10 AM |
| Mezzanine Floor |
Details
Oral e-Posters: 3 minutes presentation duration each
Speakers & Chairs
Prof Hans Clusmann
Director
Uniklinik RWTH Aachen
Chair
Dr Athanasios Chatzisotiriou
Consultant
St Luke Clinic
Chair
Dr Emilia Westarp
Resident
University Hospital Basel
Hydrocephalus in surgically treated glioblastoma patients – To treat or not to treat?
Dr Mariam Awan
Registrar
King's College Hospital
Awake Craniotomy for Diffuse Glioma in Multilingual Patients: Language Outcomes in a match cohort study
Dr Stefano Telera
Md
Irccs Istituto Nazionale Tumori Regina Elena
A real-life study on second surgery for recurrence glioblastoma
Dr FRANCESCA RONCELLI
Phd Student, Neurosurgeon
Vita-Salute San Raffaele University, San Raffaele Hospital
Immune cells subpopulations in peripheral blood in patients with high-grade gliomas
Prof Pietro Familiari
Assistant Professor
Sapienza, University Of Rome
Adult IDH Wild-Type Glioblastoma Ultrastructural Study: a Possible Correlation between Morphological Biomarkers and Ki-67 Index
Mr Timo Schenker
Resident
University Hospital Basel
CAR Macrophages for Brain Tumor Immunotherapy
Dr Pierfrancesco De Domenico
Trainee
IRCCS S. Raffaele Scientific Institute, Milan
Pre-operative Mean Platelet Volume (MPV) is associated with Glioblastoma IDH-wt overall survival, preliminary data from 167 patients
Dr Bilal Bahadır Akbulut
Resident
Ege University Faculty of Medicine
Factors Contributing to Survival of IDH Negative Glioblastomas according to WHO 2021 Classification: Is Resection Extent Relevant?
